CVS Days Of Inventory On Hand vs Ev To Sales Analysis
CVS Stock | USD 54.59 1.72 3.05% |
CVS Health financial indicator trend analysis is way more than just evaluating CVS Health Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CVS Health Corp is a good investment. Please check the relationship between CVS Health Days Of Inventory On Hand and its Ev To Sales accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Days Of Inventory On Hand vs Ev To Sales
Days Of Inventory On Hand vs Ev To Sales Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CVS Health Corp Days Of Inventory On Hand account and Ev To Sales. At this time, the significance of the direction appears to have strong relationship.
The correlation between CVS Health's Days Of Inventory On Hand and Ev To Sales is 0.63. Overlapping area represents the amount of variation of Days Of Inventory On Hand that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of CVS Health Corp, assuming nothing else is changed. The correlation between historical values of CVS Health's Days Of Inventory On Hand and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Of Inventory On Hand of CVS Health Corp are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Days Of Inventory On Hand i.e., CVS Health's Days Of Inventory On Hand and Ev To Sales go up and down completely randomly.
Correlation Coefficient | 0.63 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Days Of Inventory On Hand
Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most indicators from CVS Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CVS Health Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At this time, CVS Health's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.21 in 2024, whereas Tax Provision is likely to drop slightly above 2 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Operating Income | 13.2B | 16.3B | 13.7B | 14.4B | Other Operating Expenses | 277.1B | 306.4B | 601.0B | 631.0B |
CVS Health fundamental ratios Correlations
Click cells to compare fundamentals
CVS Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CVS Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 222.4B | 230.7B | 233.0B | 228.3B | 249.7B | 262.2B | |
Short Long Term Debt Total | 89.0B | 85.0B | 76.0B | 70.7B | 79.4B | 83.4B | |
Other Current Liab | 4.8B | 5.8B | 5.6B | 47.6B | 2.5B | 2.3B | |
Total Current Liabilities | 53.3B | 62.0B | 67.8B | 69.7B | 79.2B | 83.1B | |
Total Stockholder Equity | 63.9B | 69.4B | 75.1B | 71.0B | 76.5B | 80.3B | |
Property Plant And Equipment Net | 32.9B | 33.3B | 32.0B | 30.7B | 30.4B | 32.0B | |
Net Debt | 83.3B | 77.2B | 66.6B | 57.8B | 71.2B | 74.7B | |
Retained Earnings | 45.1B | 49.6B | 54.9B | 56.1B | 61.6B | 64.7B | |
Cash | 5.7B | 7.9B | 9.4B | 12.9B | 8.2B | 8.6B | |
Non Current Assets Total | 172.1B | 174.3B | 173.0B | 162.6B | 181.9B | 191.0B | |
Non Currrent Assets Other | 4.6B | 4.6B | 4.7B | 4.0B | 3.6B | 3.8B | |
Cash And Short Term Investments | 8.1B | 10.9B | 12.5B | 15.7B | 11.5B | 12.0B | |
Net Receivables | 19.6B | 21.7B | 24.4B | 27.3B | 35.2B | 37.0B | |
Common Stock Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 984.2M | |
Liabilities And Stockholders Equity | 222.4B | 230.7B | 233.0B | 228.3B | 249.7B | 262.2B | |
Non Current Liabilities Total | 105.0B | 99.0B | 89.8B | 87.2B | 93.9B | 98.6B | |
Inventory | 17.5B | 18.5B | 17.8B | 19.1B | 18.0B | 18.9B | |
Other Current Assets | 5.1B | 5.3B | 5.3B | 2.7B | 3.2B | 3.3B | |
Other Stockholder Equity | (28.2B) | (28.2B) | (28.2B) | (31.9B) | (33.8B) | (32.1B) | |
Total Liab | 158.3B | 161.0B | 157.6B | 157.0B | 173.1B | 181.7B | |
Property Plant And Equipment Gross | 32.9B | 33.3B | 12.9B | 12.9B | 51.1B | 53.7B | |
Total Current Assets | 50.3B | 56.4B | 60.0B | 65.7B | 67.9B | 71.3B | |
Accumulated Other Comprehensive Income | 1.0B | 1.4B | 965M | (1.5B) | (297M) | (311.9M) | |
Short Term Debt | 5.4B | 7.1B | 5.9B | 3.5B | 4.7B | 4.9B | |
Intangible Assets | 33.1B | 31.1B | 29.0B | 24.8B | 29.2B | 30.7B | |
Accounts Payable | 10.5B | 11.1B | 12.5B | 14.8B | 14.9B | 15.6B | |
Common Stock | 46.0B | 46.5B | 47.4B | 48.2B | 49.0B | 51.4B | |
Good Will | 79.7B | 79.6B | 79.1B | 78.2B | 91.3B | 95.8B | |
Common Stock Total Equity | 46.0B | 46.5B | 47.4B | 48.2B | 55.4B | 58.2B | |
Other Liab | 21.4B | 21.0B | 19.7B | 19.9B | 22.9B | 24.1B | |
Other Assets | 9.1B | 51.0B | 9.8B | 7.6B | 8.7B | 4.8B | |
Long Term Debt | 64.7B | 59.2B | 52.0B | 50.5B | 58.6B | 61.6B | |
Treasury Stock | (28.2B) | (28.2B) | (28.2B) | (31.9B) | (28.7B) | (27.2B) | |
Property Plant Equipment | 32.9B | 12.6B | 12.9B | 12.9B | 14.8B | 9.5B | |
Current Deferred Revenue | 32.6B | 38.0B | 43.8B | 3.9B | 57.1B | 60.0B | |
Short Term Investments | 2.4B | 3B | 3.1B | 2.8B | 3.3B | 3.4B | |
Net Tangible Assets | (49.0B) | (41.3B) | (33.1B) | 71.0B | 63.9B | 67.1B | |
Noncontrolling Interest In Consolidated Entity | 318M | 306M | 312M | 300M | 345M | 362.3M | |
Retained Earnings Total Equity | 45.1B | 49.6B | 54.9B | 56.1B | 64.6B | 39.9B | |
Long Term Debt Total | 64.7B | 59.2B | 52.0B | 50.5B | 58.0B | 34.0B |
Pair Trading with CVS Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.Moving against CVS Stock
0.72 | ELYM | Eliem Therapeutics Trending | PairCorr |
0.62 | DXR | Daxor | PairCorr |
0.61 | GCTK | GlucoTrack | PairCorr |
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for CVS Stock analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.10) | Dividend Share 2.42 | Earnings Share 6.47 | Revenue Per Share 277.528 | Quarterly Revenue Growth 0.12 |
The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if CVS Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.